Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean‐Yves Douillard(Centre d'Investigation Clinique de Nantes), Rafael Rosell(Institut Català d'Oncologia), Mario De Lena(Istituti di Ricovero e Cura a Carattere Scientifico), Francesco Carpagnano(Ospedale San Paolo), Rodryg Ramlau(Instytut Gruźlicy i Chorób Płuc), Jose Luis Gonzáles-Larriba(Hospital Clínico San Carlos), Tomasz Grodzki(University of Szczecin), José Rodrigues Pereira(Instituto do Câncer do Estado de São Paulo), A. Le Groumellec(Centre hospitalier Bretagne Atlantique), Vito Lorusso(Ospedale Antonio Cardarelli), C. Clary, Antonio J. Torres(Hospital Clínico San Carlos), Jabrail Dahabreh(Sismanoglio General Hospital), Pierre‐Jean Souquet(Hôpital Lyon Sud), Julio Astudillo(Hospital Universitari Germans Trias i Pujol), P. Fournel(Hôpital Nord), Á. Artal(Hospital Universitario Miguel Servet), Jacek Jassem, Leona Koubková, Patricia His(Pierre Fabre (France)), M Riggi(Pierre Fabre (France)), P Hurteloup(Pierre Fabre (France))
Cited by 1,587
Abstract
Related Papers
No related papers found
Powered by citation graph analysis